Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.

Identifieur interne : 000A30 ( Main/Exploration ); précédent : 000A29; suivant : 000A31

Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.

Auteurs : Hina Faisal ; Alexi Bloom ; A Osama Gaber [États-Unis]

Source :

RBID : pubmed:32909713

Descripteurs français

English descriptors

Abstract

Methemoglobinemia is a rare disorder of the blood in which there is an increase in methemoglobin, which occurs when hemoglobin is present in the oxidized form. Methemoglobin impairs hemoglobin's ability to transport oxygen, produces functional anemia, and leads to tissue hypoxia. We report the successful management of a case of refractory hypoxia due to acutely acquired methemoglobinemia in a patient undergoing treatment for coronavirus disease 2019 (COVID-19) pneumonia. The cause of methemoglobinemia in this patient remains unknown. Hypoxia and methemoglobinemia did not respond to methylene blue and required administration of packed red blood cell transfusions.

DOI: 10.1213/XAA.0000000000001287
PubMed: 32909713
PubMed Central: PMC7373357


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.</title>
<author>
<name sortKey="Faisal, Hina" sort="Faisal, Hina" uniqKey="Faisal H" first="Hina" last="Faisal">Hina Faisal</name>
<affiliation>
<nlm:affiliation>From the Department of Surgery & Critical Care.</nlm:affiliation>
<wicri:noCountry code="no comma">From the Department of Surgery & Critical Care.</wicri:noCountry>
<wicri:noCountry code="no comma">From the Department of Surgery & Critical Care.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bloom, Alexi" sort="Bloom, Alexi" uniqKey="Bloom A" first="Alexi" last="Bloom">Alexi Bloom</name>
<affiliation>
<nlm:affiliation>Department of Surgery.</nlm:affiliation>
<wicri:noCountry code="no comma">Department of Surgery.</wicri:noCountry>
<wicri:noCountry code="no comma">Department of Surgery.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Gaber, A Osama" sort="Gaber, A Osama" uniqKey="Gaber A" first="A Osama" last="Gaber">A Osama Gaber</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Surgery & Transplant Center, Houston Methodist Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgery & Transplant Center, Houston Methodist Hospital, Houston</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Weill Cornell Medical College, New York, New York.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Weill Cornell Medical College, New York</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32909713</idno>
<idno type="pmid">32909713</idno>
<idno type="doi">10.1213/XAA.0000000000001287</idno>
<idno type="pmc">PMC7373357</idno>
<idno type="wicri:Area/Main/Corpus">000C48</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C48</idno>
<idno type="wicri:Area/Main/Curation">000C48</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C48</idno>
<idno type="wicri:Area/Main/Exploration">000C48</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.</title>
<author>
<name sortKey="Faisal, Hina" sort="Faisal, Hina" uniqKey="Faisal H" first="Hina" last="Faisal">Hina Faisal</name>
<affiliation>
<nlm:affiliation>From the Department of Surgery & Critical Care.</nlm:affiliation>
<wicri:noCountry code="no comma">From the Department of Surgery & Critical Care.</wicri:noCountry>
<wicri:noCountry code="no comma">From the Department of Surgery & Critical Care.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bloom, Alexi" sort="Bloom, Alexi" uniqKey="Bloom A" first="Alexi" last="Bloom">Alexi Bloom</name>
<affiliation>
<nlm:affiliation>Department of Surgery.</nlm:affiliation>
<wicri:noCountry code="no comma">Department of Surgery.</wicri:noCountry>
<wicri:noCountry code="no comma">Department of Surgery.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Gaber, A Osama" sort="Gaber, A Osama" uniqKey="Gaber A" first="A Osama" last="Gaber">A Osama Gaber</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Surgery & Transplant Center, Houston Methodist Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Surgery & Transplant Center, Houston Methodist Hospital, Houston</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Weill Cornell Medical College, New York, New York.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Weill Cornell Medical College, New York</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">A&A practice</title>
<idno type="eISSN">2575-3126</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acute Kidney Injury (complications)</term>
<term>Acute Kidney Injury (therapy)</term>
<term>Aged (MeSH)</term>
<term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Antioxidants (therapeutic use)</term>
<term>Ascorbic Acid (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Corynebacterium (MeSH)</term>
<term>Corynebacterium Infections (complications)</term>
<term>Corynebacterium Infections (therapy)</term>
<term>Cytokine Release Syndrome (complications)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Erythrocyte Transfusion (MeSH)</term>
<term>Hematinics (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Hydroxocobalamin (therapeutic use)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Hypoxia (etiology)</term>
<term>Hypoxia (therapy)</term>
<term>Male (MeSH)</term>
<term>Methemoglobinemia (complications)</term>
<term>Methemoglobinemia (therapy)</term>
<term>Methylene Blue (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Bacterial (complications)</term>
<term>Pneumonia, Bacterial (therapy)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Renal Replacement Therapy (MeSH)</term>
<term>Respiratory Insufficiency (etiology)</term>
<term>Respiratory Insufficiency (therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Shock, Septic (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide ascorbique (usage thérapeutique)</term>
<term>Antianémiques (usage thérapeutique)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Antienzymes (usage thérapeutique)</term>
<term>Antioxydants (usage thérapeutique)</term>
<term>Atteinte rénale aigüe (complications)</term>
<term>Atteinte rénale aigüe (thérapie)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Bleu de méthylène (usage thérapeutique)</term>
<term>Choc septique (complications)</term>
<term>Corynebacterium (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxocobalamine (usage thérapeutique)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Hypoxie (thérapie)</term>
<term>Hypoxie (étiologie)</term>
<term>Infections à Corynebacterium (complications)</term>
<term>Infections à Corynebacterium (thérapie)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Insuffisance respiratoire (thérapie)</term>
<term>Insuffisance respiratoire (étiologie)</term>
<term>Mâle (MeSH)</term>
<term>Méthémoglobinémie (complications)</term>
<term>Méthémoglobinémie (thérapie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie bactérienne (complications)</term>
<term>Pneumopathie bactérienne (thérapie)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Sujet âgé (MeSH)</term>
<term>Traitement substitutif de l'insuffisance rénale (MeSH)</term>
<term>Transfusion d'érythrocytes (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized</term>
<term>Antioxidants</term>
<term>Ascorbic Acid</term>
<term>Enzyme Inhibitors</term>
<term>Hematinics</term>
<term>Hydroxocobalamin</term>
<term>Hydroxychloroquine</term>
<term>Methylene Blue</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Acute Kidney Injury</term>
<term>Coronavirus Infections</term>
<term>Corynebacterium Infections</term>
<term>Cytokine Release Syndrome</term>
<term>Methemoglobinemia</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Viral</term>
<term>Shock, Septic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Hypoxia</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Acute Kidney Injury</term>
<term>Corynebacterium Infections</term>
<term>Hypoxia</term>
<term>Methemoglobinemia</term>
<term>Pneumonia, Bacterial</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Atteinte rénale aigüe</term>
<term>Hypoxie</term>
<term>Infections à Corynebacterium</term>
<term>Insuffisance respiratoire</term>
<term>Méthémoglobinémie</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Acide ascorbique</term>
<term>Antianémiques</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Antienzymes</term>
<term>Antioxydants</term>
<term>Atteinte rénale aigüe</term>
<term>Bleu de méthylène</term>
<term>Choc septique</term>
<term>Hydroxocobalamine</term>
<term>Hydroxychloroquine</term>
<term>Infections à Corynebacterium</term>
<term>Infections à coronavirus</term>
<term>Méthémoglobinémie</term>
<term>Pneumopathie bactérienne</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Hypoxie</term>
<term>Insuffisance respiratoire</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Corynebacterium</term>
<term>Erythrocyte Transfusion</term>
<term>Humans</term>
<term>Male</term>
<term>Pandemics</term>
<term>Renal Replacement Therapy</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Corynebacterium</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
<term>Traitement substitutif de l'insuffisance rénale</term>
<term>Transfusion d'érythrocytes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Methemoglobinemia is a rare disorder of the blood in which there is an increase in methemoglobin, which occurs when hemoglobin is present in the oxidized form. Methemoglobin impairs hemoglobin's ability to transport oxygen, produces functional anemia, and leads to tissue hypoxia. We report the successful management of a case of refractory hypoxia due to acutely acquired methemoglobinemia in a patient undergoing treatment for coronavirus disease 2019 (COVID-19) pneumonia. The cause of methemoglobinemia in this patient remains unknown. Hypoxia and methemoglobinemia did not respond to methylene blue and required administration of packed red blood cell transfusions.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32909713</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>03</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2575-3126</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>A&A practice</Title>
<ISOAbbreviation>A A Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.</ArticleTitle>
<Pagination>
<MedlinePgn>e01287</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1213/XAA.0000000000001287</ELocationID>
<Abstract>
<AbstractText>Methemoglobinemia is a rare disorder of the blood in which there is an increase in methemoglobin, which occurs when hemoglobin is present in the oxidized form. Methemoglobin impairs hemoglobin's ability to transport oxygen, produces functional anemia, and leads to tissue hypoxia. We report the successful management of a case of refractory hypoxia due to acutely acquired methemoglobinemia in a patient undergoing treatment for coronavirus disease 2019 (COVID-19) pneumonia. The cause of methemoglobinemia in this patient remains unknown. Hypoxia and methemoglobinemia did not respond to methylene blue and required administration of packed red blood cell transfusions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Faisal</LastName>
<ForeName>Hina</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Surgery & Critical Care.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bloom</LastName>
<ForeName>Alexi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaber</LastName>
<ForeName>A Osama</ForeName>
<Initials>AO</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery & Transplant Center, Houston Methodist Hospital, Houston, Texas.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>A A Pract</MedlineTA>
<NlmUniqueID>101714112</NlmUniqueID>
<ISSNLinking>2575-3126</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006397">Hematinics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>I031V2H011</RegistryNumber>
<NameOfSubstance UI="C502936">tocilizumab</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PQ6CK8PD0R</RegistryNumber>
<NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Q40X8H422O</RegistryNumber>
<NameOfSubstance UI="D006879">Hydroxocobalamin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>T42P99266K</RegistryNumber>
<NameOfSubstance UI="D008751">Methylene Blue</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003352" MajorTopicYN="N">Corynebacterium</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003354" MajorTopicYN="N">Corynebacterium Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006397" MajorTopicYN="N">Hematinics</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006879" MajorTopicYN="N">Hydroxocobalamin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008708" MajorTopicYN="N">Methemoglobinemia</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008751" MajorTopicYN="N">Methylene Blue</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>10</Day>
<Hour>10</Hour>
<Minute>29</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32909713</ArticleId>
<ArticleId IdType="doi">10.1213/XAA.0000000000001287</ArticleId>
<ArticleId IdType="pii">02054229-202007000-00014</ArticleId>
<ArticleId IdType="pmc">PMC7373357</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999; 34:646–656</Citation>
</Reference>
<Reference>
<Citation>Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011; 104:757–761</Citation>
</Reference>
<Reference>
<Citation>Alanazi MQ. Drugs may be induced methemoglobinemia. J Hematol Thrombo Dis. 2017; 270:1–5</Citation>
</Reference>
<Reference>
<Citation>Wenzhong L, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv. 2020. Preprint. https://doi.org/10.26434/chemrxiv.11938173.v7.</Citation>
</Reference>
<Reference>
<Citation>Ohashi K, Yukioka H, Hayashi M, Asada A. Elevated methemoglobin in patients with sepsis. Acta Anaesthesiol Scand. 1998; 42:713–716</Citation>
</Reference>
<Reference>
<Citation>Wilkerson RG. Getting the blues at a rock concert: a case of severe methaemoglobinaemia. Emerg Med Australas. 2010; 22:466–469</Citation>
</Reference>
<Reference>
<Citation>Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005; 51:434–444</Citation>
</Reference>
<Reference>
<Citation>Watcha MF, Connor MT, Hing AV. Pulse oximetry in methemoglobinemia. Am J Dis Child. 1989; 143:845–847</Citation>
</Reference>
<Reference>
<Citation>Brunelle JA, Degtiarov AM, Moran RF, Race LA. Simultaneous measurement of total hemoglobin and its derivatives in blood using CO-oximeters: analytical principles; their application in selecting analytical wavelengths and reference methods; a comparison of the results of the choices made. Scand J Clin Lab Invest Suppl. 1996; 224:47–69</Citation>
</Reference>
<Reference>
<Citation>Rehman HU. Methemoglobinemia. West J Med. 2001; 175:193–196</Citation>
</Reference>
<Reference>
<Citation>Pritchett MA, Celestin N, Tilluckdharry N, Hendra K, Lee P. Successful treatment of refractory methemoglobinemia with red blood cell exchange transfusion. Chest. 2006; 130:294S</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
<li>État de New York</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Bloom, Alexi" sort="Bloom, Alexi" uniqKey="Bloom A" first="Alexi" last="Bloom">Alexi Bloom</name>
<name sortKey="Faisal, Hina" sort="Faisal, Hina" uniqKey="Faisal H" first="Hina" last="Faisal">Hina Faisal</name>
</noCountry>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Gaber, A Osama" sort="Gaber, A Osama" uniqKey="Gaber A" first="A Osama" last="Gaber">A Osama Gaber</name>
</region>
<name sortKey="Gaber, A Osama" sort="Gaber, A Osama" uniqKey="Gaber A" first="A Osama" last="Gaber">A Osama Gaber</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A30 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A30 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32909713
   |texte=   Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32909713" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021